Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM®) for accelerated partial breast irradiation (APBI).
Laplana M, García-Marqueta M, Sánchez-Fernández JJ, Martínez-Pérez E, Pérez-Montero H, Martínez-Montesinos I, Eraso A, Saldaña P, Martín R, Martín MI, Pla MJ, García-Tejedor A, Guedea F. Laplana M, et al. Among authors: perez montero h. Clin Transl Oncol. 2022 Sep;24(9):1732-1743. doi: 10.1007/s12094-022-02823-w. Epub 2022 Mar 19. Clin Transl Oncol. 2022. PMID: 35305245
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, Perez-Montero H, Fernandez-Montolí E, Stradella A, Recalde S, Soler T, Petit A, Bajen MT, Benitez A, Guma A, Campos M, Pla MJ, Martinez E, Laplana M, Pernas S, Perez-Sildekova D, Catala I, Ponce J, Falo C. Garcia-Tejedor A, et al. Among authors: perez montero h. Breast Cancer Res Treat. 2021 Feb;185(3):657-666. doi: 10.1007/s10549-020-05970-2. Epub 2020 Oct 17. Breast Cancer Res Treat. 2021. PMID: 33068198
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
Ortega Expósito C, Falo C, Pernas S, Pérez Carton S, Gil Gil M, Ortega R, Pérez Montero H, Stradella A, Martinez E, Laplana M, Salinas S, Luzardo A, Soler T, Fernández Montoli ME, Azcarate J, Guma A, Petit A, Benitez A, Bajen M, Reyes Junca JG, Campos M, Ruiz R, Ponce J, Pla MJ, García Tejedor A. Ortega Expósito C, et al. Among authors: perez montero h. Breast Cancer Res Treat. 2021 Aug;189(1):111-120. doi: 10.1007/s10549-021-06274-9. Epub 2021 Jun 4. Breast Cancer Res Treat. 2021. PMID: 34089119
Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
Stefanovic M, Calvet G, Pérez-Montero H, Esteve A, Bujalance MV, Navarro-Martín A, Fernández MDA, González FF, Borras SM, Borbalas AL, Fernandez MN, Garau MM, Calduch AL, Edo FG. Stefanovic M, et al. Among authors: perez montero h. Clin Transl Oncol. 2023 Jan;25(1):199-206. doi: 10.1007/s12094-022-02923-7. Epub 2022 Sep 6. Clin Transl Oncol. 2023. PMID: 36068449
Long-term outcomes of spinal SBRT. Is it important to select the treatment time?
Pérez-Montero H, Godino O, Lozano A, Asiáin L, Martínez I, Sánchez JJ, de BlasFernández R, Fernández E, Stefanovic M, García N, Martínez J, Guedea F, Navarro-Martin A. Pérez-Montero H, et al. Clin Transl Oncol. 2022 Feb;24(2):276-287. doi: 10.1007/s12094-021-02684-9. Epub 2021 Aug 3. Clin Transl Oncol. 2022. PMID: 34342817
Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy.
Salinas-Huertas S, Luzardo-González A, Vázquez-Gallego S, Pernas S, Falo C, Pla MJ, Gil-Gil M, Beranuy-Rodriguez M, Pérez-Montero H, Gomila-Sancho M, Manent-Molina N, Arencibia-Domínguez A, Gonzalez-Pineda B, Tormo-Collado F, Ortí-Asencio M, Terra J, Martinez-Perez E, Mestre-Jane A, Campos-Varela I, Jaraba-Armas M, Benítez-Segura A, Campos-Delgado M, Fernández-Montolí ME, Valverde-Alcántara Y, Rodríguez A, Campos G, Guma A, Ponce-Sebastià J, Planas-Balagué R, Catasús-Clavé M, García-Tejedor A. Salinas-Huertas S, et al. Among authors: perez montero h. Breast Dis. 2022;41(1):97-108. doi: 10.3233/BD-210043. Breast Dis. 2022. PMID: 34542055
Rescuing Spanish Radiation Therapy: The Role of Leadership and Opportunity.
Lara PC, Rodríguez A, Ferrer C, Aristu JJ, Prada PJ, Muñoz J, Arenas M, Perez-Montero H. Lara PC, et al. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):292-296. doi: 10.1016/j.ijrobp.2017.09.006. Int J Radiat Oncol Biol Phys. 2018. PMID: 29353648 No abstract available.
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Rodríguez A, Arenas M, Lara PC, López-Torrecilla J, Algara M, Conde A, Pérez-Montero H, Muñoz JL, Peleteiro P, Pérez-Calatayud MJ, Contreras J, Ferrer C; Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group. Rodríguez A, et al. Clin Transl Oncol. 2019 Dec;21(12):1663-1672. doi: 10.1007/s12094-019-02095-x. Epub 2019 Apr 3. Clin Transl Oncol. 2019. PMID: 30941701
16 results